Acceleron Pharma Inc. Current Ratio 2013-2021 | XLRN
Acceleron Pharma Inc. current ratio from 2013 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2021-09-30 | $0.70B | $0.06B | 12.14 |
| 2021-06-30 | $0.72B | $0.06B | 12.07 |
| 2021-03-31 | $0.74B | $0.05B | 14.81 |
| 2020-12-31 | $0.89B | $0.06B | 14.85 |
| 2020-09-30 | $0.91B | $0.04B | 24.50 |
| 2020-06-30 | $0.45B | $0.04B | 12.02 |
| 2020-03-31 | $0.43B | $0.03B | 15.15 |
| 2019-12-31 | $0.45B | $0.03B | 13.48 |
| 2019-09-30 | $0.44B | $0.03B | 14.02 |
| 2019-06-30 | $0.45B | $0.03B | 17.11 |
| 2019-03-31 | $0.45B | $0.02B | 19.26 |
| 2018-12-31 | $0.31B | $0.02B | 16.18 |
| 2018-09-30 | $0.32B | $0.02B | 21.68 |
| 2018-06-30 | $0.30B | $0.02B | 20.53 |
| 2018-03-31 | $0.30B | $0.01B | 23.20 |
| 2017-12-31 | $0.29B | $0.02B | 17.04 |
| 2017-09-30 | $0.34B | $0.02B | 21.62 |
| 2017-06-30 | $0.15B | $0.01B | 10.38 |
| 2017-03-31 | $0.15B | $0.02B | 9.81 |
| 2016-12-31 | $0.15B | $0.02B | 9.09 |
| 2016-09-30 | $0.15B | $0.02B | 8.95 |
| 2016-06-30 | $0.13B | $0.01B | 9.28 |
| 2016-03-31 | $0.17B | $0.02B | 11.25 |
| 2015-12-31 | $0.11B | $0.01B | 7.66 |
| 2015-09-30 | $0.12B | $0.01B | 9.51 |
| 2015-06-30 | $0.12B | $0.01B | 10.58 |
| 2015-03-31 | $0.11B | $0.01B | 11.02 |
| 2014-12-31 | $0.18B | $0.01B | 19.70 |
| 2014-09-30 | $0.20B | $0.01B | 17.68 |
| 2014-06-30 | $0.21B | $0.02B | 13.06 |
| 2014-03-31 | $0.22B | $0.01B | 23.78 |
| 2013-12-31 | $0.12B | $0.03B | 4.37 |
| 2013-09-30 | $0.12B | $0.02B | 7.43 |
| 2013-06-30 | $0.00B | 0.00 | |
| 2013-03-31 | $0.00B | 0.00 | |
| 2012-09-30 | $0.00B | 0.00 | |
